HCM — HUTCHMED (China) Share News
0.000.00%
Last trade - 00:00
- £2.34bn
- £1.70bn
- $838.00m
- 85
- 20
- 62
- 57
REG - Hutchmed China Ltd - Holding(s) in Company
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED To Present FRESCO-2 Data at ESMO 2022
AnnouncementRCS - Hutchmed China Ltd - First Participant in Phase I Trial of IMG-004
AnnouncementRCS - Hutchmed China Ltd - Preliminary results from SAVANNAH Phase 2 Trial
AnnouncementREG - Hutchmed China Ltd - FRESCO-2 Study Has Met Primary Endpoint
AnnouncementREG - Hutchmed China Ltd - Interim Results and Business Updates
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Initiates Bridging Study of Tazemetostat
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Initiates Phase I Trial of HMPL-A83
AnnouncementRCS - Hutchmed China Ltd - Results of SAVANNAH Global Phase II Trial at WCLC
AnnouncementRCS - Hutchmed China Ltd - First Participants in Phase I Trial of IMG-007
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
AnnouncementREG - Hutchmed China Ltd - Blocklisting Six Monthly Return
AnnouncementREG - Hutchmed China Ltd - HUTCHMED to Announce 2022 Half-Year Results
AnnouncementRCS - Hutchmed China Ltd - TAZVERIK® Approved in Hainan Pilot Zone
AnnouncementREG - Hutchmed China Ltd - LTIP and Share Options
AnnouncementREG - Hutchmed China Ltd - Appointment of Non–Executive Director
AnnouncementREG - Hutchmed China Ltd - HUTCHMED Receives CRL from the US FDA
AnnouncementREG - Hutchmed China Ltd - Annual General Meeting Poll Results
AnnouncementREG - Hutchmed China Ltd - Vesting of awards under Long Term Incentive Plan
Announcement